Nintedanib Impurity 19 | CAS 2095628-55-8 - Request Quote
Nintedanib Impurity 19
| SZ CAT No: | SZ-N023030 |
| CAS No | 2095628-55-8 |
| Mol.F. | C20H19NO4 |
| Mol.Wt. | 337.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 19 is chemically Ethyl 3-(ethoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate. Nintedanib Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2095628-55-8
Purchase 2095628-55-8
Order 2095628-55-8
Enquire 2095628-55-8
price of 2095628-55-8
2095628-55-8 Supplier
2095628-55-8 Manufacturer
2095628-55-8 Exporter
buy high quality Nintedanib Impurity 19
Purchase Nintedanib Impurity 19
Nintedanib Impurity 19 suppliers
Nintedanib Impurity 19 manufacturers
Nintedanib Impurity 19 price
Order Nintedanib Impurity 19
Enquire Nintedanib Impurity 19
Nintedanib Impurity 19 cost
Nintedanib Impurity 19 Supplier
Nintedanib Impurity 19 Distributor
Nintedanib Impurity 19 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 19 for ANDA Filing
Nintedanib Impurity 19 for Forced Degradation Studies
Nintedanib Impurity 19 Identification Standards
Nintedanib Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.